In vitro evaluation of Bacopa monniera extract and individual constituents on human recombinant monoamine oxidase enzymes

Phytotherapy Research

Volumn 28, Issue 9, 2014, Pages 1419-1422

  Singh, Rajbir ^a   Ramakrishna, Rachumallu ^a,b   Bhateria, Manisha ^a,b   Bhatta, Rabi Sankar ^a,b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Bacopa monniera; Bacoside; Monoamine oxidase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BACOPA MONNIERI EXTRACT; BACOPASIDE I; BACOPASIDE II; BACOPASIDE II PLUS BACOSIDE A3 PLUS BACOSAPONIN C PLUS BACOSAPONIN C ISOMER; BACOSAPONIN C; BACOSIDE A3; BACOSINE; MONOAMINE OXIDASE INHIBITOR; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; BACOSIDE; MONOAMINE OXIDASE A, HUMAN; PLANT EXTRACT; RECOMBINANT PROTEIN; SAPONIN; TRITERPENE;

ARTICLE; BACOPA MONNIERI; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; DRUG SCREENING; ENZYME INHIBITION; HUMAN; IC50; IN VITRO STUDY; INHIBITION CONSTANT; INHIBITION KINETICS; BACOPA; CHEMISTRY; METABOLISM;

BACOPA MONNIERA; BACOSIDE; MONOAMINE OXIDASE;

BACOPA; HUMANS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLANT EXTRACTS; RECOMBINANT PROTEINS; SAPONINS; TRITERPENES;

EID: 84907920004     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5116     Document Type: Article

References (13)

1. Abell CW, Kwan SW. 2001. Molecular characterization of monoamine oxidases A and B. Prog Nucleic Acid Res Mol Biol 65: 129-156.
2. Damier P, Kastner A, Agid Y, Hirsch EC. 1996. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology 46: 1262-1269.
3. Das A, Shanker G, Nath C, Pal R, Singh S, Singh H. 2002. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba : anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav 73 : 893-900.
4. Fernandes MH, Soares-da-Silva P. 1992. Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 145: 363-367.
5. Hou C-C, Lin S-J, Cheng J-T, Hsu F-L. 2002. Bacopaside III, bacopasaponin G, and bacopasides A, B, and C from Bacopa monniera. J Nat Prod 65: 1759-1763.
6. Hou WC, Lin RD, Chen CT, Lee MH. 2005. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. J Ethnopharmacol 100: 216-220.
7. Kielholz P. 1986. Treatment for therapy-resistant depression. Psychopathology 19(Suppl 2): 194-200.
8. Laux G, Classen W, Sofic E, et al. 1990. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder. J Neural Transm Suppl 32: 189-195.
9. Lin RD, Hou WC, Yen KY, Lee MH. 2003. Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines. Phytomedicine 10: 650-656.
10. Maki Y. 2001. A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors. Hokkaido Igaku Zasshi 76: 133-142.
11. Russo A, Borrelli F. 2005. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 12: 305-317.
12. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. 2002. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 9: 207-211.
13. Sheu SY, Lin CY, Wu JD, Chiang HC. 1999. Inhibition of xanthine oxidase by benzothiazinone analogues. Anticancer Res 19: 119-123.